PerrigoPRGO
About: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Employees: 9,140
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
390% more call options, than puts
Call options by funds: $54.2M | Put options by funds: $11.1M
8% more repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 121
2% more capital invested
Capital invested by funds: $3.34B [Q2] → $3.42B (+$79.3M) [Q3]
0.18% more ownership
Funds ownership: 95.49% [Q2] → 95.67% (+0.18%) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 9 [Q2] → 9 (+0) [Q3]
4% less funds holding
Funds holding: 355 [Q2] → 342 (-13) [Q3]
23% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 56
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Canaccord Genuity Susan Anderson 61% 1-year accuracy 11 / 18 met price target | 48%upside $42 | Buy Maintained | 30 Sept 2024 |
Jefferies Keith Devas 100% 1-year accuracy 1 / 1 met price target | 6%upside $30 | Hold Downgraded | 23 Sept 2024 |
Financial journalist opinion
Based on 7 articles about PRGO published over the past 30 days